UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bone Dysplasia Sclerosteosis Results from Loss of the SOST Gene Product, a Novel Cystine Knot–Containing Protein

American journal of human genetics, 2001-03, Vol.68 (3), p.577-589

2001

Volltextzugriff (PDF)

Differential Effects of Tipranavir plus Ritonavir on Atorvastatin or Rosuvastatin Pharmacokinetics in Healthy Volunteers

Antimicrobial Agents and Chemotherapy, 2009-10, Vol.53 (10), p.4385-4392

2009

Volltextzugriff (PDF)

A Phenotype-Genotype Approach to Predicting CYP450 and P-Glycoprotein Drug Interactions With the Mixed Inhibitor/Inducer Tipranavir/Ritonavir

Clinical pharmacology and therapeutics, 2010-06, Vol.87 (6), p.735-742

2010

Volltextzugriff (PDF)

Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis

Journal of Bacteriology, 1996-03, Vol.178 (5), p.1274-1282

1996

Volltextzugriff (PDF)

Lack of Effect of Efavirenz on the Pharmacokinetics of Tipranavir-Ritonavir in Healthy Volunteers

Antimicrobial Agents and Chemotherapy, 2009-11, Vol.53 (11), p.4840-4844

2009

Volltextzugriff (PDF)

Contribution of Major Metabolites toward Complex Drug-Drug Interactions of Deleobuvir: In Vitro Predictions and In Vivo Outcomes

Drug metabolism and disposition, 2016-03, Vol.44 (3), p.466-475

2016

Volltextzugriff (PDF)

Disparate Responses to Oxidative Stress in Saprophytic and Pathogenic Mycobacteria

Proceedings of the National Academy of Sciences - PNAS, 1995-07, Vol.92 (14), p.6625-6629

1995

Volltextzugriff (PDF)

Effect of Tipranavir/Ritonavir Combination on the Pharmacokinetics of Tadalafil in Healthy Volunteers

Journal of clinical pharmacology, 2011-07, Vol.51 (7), p.1071-1078

2011

Volltextzugriff (PDF)

BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine

Antimicrobial Agents and Chemotherapy, 1991-02, Vol.35 (2), p.305-308

1991

Volltextzugriff (PDF)

Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers

Biopharmaceutics & drug disposition, 1999-09, Vol.20 (6), p.285-291

1999

Volltextzugriff (PDF)

Transcription Factor AP1 Potentiates Chromatin Accessibility and Glucocorticoid Receptor Binding

Molecular cell, 2011-07, Vol.43 (1), p.145-155

2011

Volltextzugriff (PDF)

Isotype choice for chimeric antibodies affects binding properties

The Journal of biological chemistry, 1994-04, Vol.269 (17), p.13048-13055

1994

Volltextzugriff (PDF)

Clinical Assessment of Potential Drug Interactions of Faldaprevir, a Hepatitis C Virus Protease Inhibitor, With Darunavir/Ritonavir, Efavirenz, and Tenofovir

Clinical infectious diseases, 2014-11, Vol.59 (10), p.1420-1428

2014

Volltextzugriff (PDF)

Chronicling the Chronicler: The Book of Chronicles and Early Second Temple Historiography

2013

Volltextzugriff (PDF)

Chronicling the Chronicler: The Book of Chronicles and Early Second Temple Historiography

1, 2013

Volltextzugriff (PDF)

Discovery of Functional Noncoding Elements by Digital Analysis of Chromatin Structure

Proceedings of the National Academy of Sciences - PNAS, 2004-11, Vol.101 (48), p.16837-16842

2004

Volltextzugriff (PDF)

Genome-Wide Identification of DNasel Hypersensitive Sites Using Active Chromatin Sequence Libraries

Proceedings of the National Academy of Sciences - PNAS, 2004-03, Vol.101 (13), p.4537-4542

2004

Volltextzugriff (PDF)

Effects of the Clara cell toxin, 4-ipomeanol, on pulmonary function in rats

Journal of applied physiology (1985), 1983-02, Vol.54 (2), p.337-344

1983

Volltextzugriff (PDF)

Combined tipranavir and enfuvirtide use associated with higher plasma tipranavir concentrations but not with increased hepatotoxicity : sub-analysis from RESIST

AIDS (London), 2007-09, Vol.21 (14), p.1977-1980

2007

Volltextzugriff (PDF)

Interaction of Ritonavir-Boosted Tipranavir with Loperamide Does Not Result in Loperamide-Associated Neurologic Side Effects in Healthy Volunteers

Antimicrobial Agents and Chemotherapy, 2005-12, Vol.49 (12), p.4903-4910

2005

Volltextzugriff (PDF)

Seeking Saul in Chronicles

Chronicling the Chronicler, 2021, p.43-64

2021

Volltextzugriff (PDF)

Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone

Drug and alcohol dependence, 2009-12, Vol.105 (3), p.234-239

2009

Volltextzugriff (PDF)

A Phenotype-Genotype Approach to Predicting CYP450 and P-Glycoprotein Drug Interactions With the Mixed Inhibitor/ InducerTipranavir/Ritonavir

Clinical pharmacology and therapeutics, 2010, Vol.87 (6), p.735-742

2010

Volltextzugriff (PDF)

The effect of selected drugs on first-stage radioemesis in beagle dogs

Radiation research, 1979-05, Vol.78 (2), p.286

1979

Volltextzugriff (PDF)

Genome-wide identification of DNaseI hypersensitive sites using active chromatin sequence libraries

Proceedings of the National Academy of Sciences - PNAS, 2004-03, Vol.101 (13), p.4537-4542

2004

Volltextzugriff (PDF)

1 – 25 von 306

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(278)
Mit Volltextzugriff
(245)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(225)
Life Sciences & Biomedicine
(181)
Humans
(123)
Male
(73)
Female
(67)
Biological And Medical Sciences
(66)
Medical Sciences
(52)
Animals
(47)
Technology
(40)
Adult
(35)
Sport Sciences
(33)
Engineering
(31)
Middle Aged
(28)
Engineering, Multidisciplinary
(27)
Physical Sciences
(26)
Adolescent
(25)
Fundamental And Applied Biological Sciences. Psychology
(20)
Biochemistry & Molecular Biology
(19)
Science & Technology - Other Topics
(19)
Child
(18)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bone Dysplasia Sclerosteosis Results from Loss of the SOST Gene Product, a Novel Cystine Knot–Containing Protein

Differential Effects of Tipranavir plus Ritonavir on Atorvastatin or Rosuvastatin Pharmacokinetics in Healthy Volunteers

A Phenotype-Genotype Approach to Predicting CYP450 and P-Glycoprotein Drug Interactions With the Mixed Inhibitor/Inducer Tipranavir/Ritonavir

Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis

Lack of Effect of Efavirenz on the Pharmacokinetics of Tipranavir-Ritonavir in Healthy Volunteers

Contribution of Major Metabolites toward Complex Drug-Drug Interactions of Deleobuvir: In Vitro Predictions and In Vivo Outcomes

Disparate Responses to Oxidative Stress in Saprophytic and Pathogenic Mycobacteria

Effect of Tipranavir/Ritonavir Combination on the Pharmacokinetics of Tadalafil in Healthy Volunteers

BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine

Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers

Transcription Factor AP1 Potentiates Chromatin Accessibility and Glucocorticoid Receptor Binding

Isotype choice for chimeric antibodies affects binding properties

Clinical Assessment of Potential Drug Interactions of Faldaprevir, a Hepatitis C Virus Protease Inhibitor, With Darunavir/Ritonavir, Efavirenz, and Tenofovir

Chronicling the Chronicler: The Book of Chronicles and Early Second Temple Historiography

Chronicling the Chronicler: The Book of Chronicles and Early Second Temple Historiography

Discovery of Functional Noncoding Elements by Digital Analysis of Chromatin Structure

Genome-Wide Identification of DNasel Hypersensitive Sites Using Active Chromatin Sequence Libraries

Effects of the Clara cell toxin, 4-ipomeanol, on pulmonary function in rats

Combined tipranavir and enfuvirtide use associated with higher plasma tipranavir concentrations but not with increased hepatotoxicity : sub-analysis from RESIST

Interaction of Ritonavir-Boosted Tipranavir with Loperamide Does Not Result in Loperamide-Associated Neurologic Side Effects in Healthy Volunteers

Seeking Saul in Chronicles

Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone

A Phenotype-Genotype Approach to Predicting CYP450 and P-Glycoprotein Drug Interactions With the Mixed Inhibitor/ InducerTipranavir/Ritonavir

The effect of selected drugs on first-stage radioemesis in beagle dogs

Genome-wide identification of DNaseI hypersensitive sites using active chromatin sequence libraries

Suchergebnisse filtern